Previous Article | Next Article ![]()
Infection and Immunity, March 2009, p. 943-951, Vol. 77, No. 3
0019-9567/09/$08.00+0 doi:10.1128/IAI.01267-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Dena Lyras,1
Leanne M. Cordner,1
Jody Melton-Witt,2,
John J. Emmins,3
Rodney K. Tweten,2 and
Julian I. Rood1*
Australian Bacterial Pathogenesis Program, Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia,1 Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190,2 Department of Immunology, Monash University, Prahran, Victoria 3004, Australia3
Received 16 October 2008/ Returned for modification 26 November 2008/ Accepted 2 January 2009
Clostridium septicum alpha-toxin is a β-barrel pore-forming cytolysin that is functionally similar to aerolysin. Residues important in receptor binding, oligomerization, and pore formation have been identified; however, little is known about the activity of the toxin in an infection, although it is essential for disease. We have now shown that deletion of a small portion of the transmembrane domain, so that the toxin is no longer able to form pores, completely abrogates its ability to contribute to disease, as does replacement of the sole cysteine residue with leucine. However, although previous biochemical and cytotoxicity assays clearly indicated that mutations in residues important in oligomerization, binding, and prepore conversion greatly reduced activity or rendered the toxin inactive, once the mutated toxins were overexpressed by the natural host in the context of an infection it was found they were able to cause disease in a mouse model of myonecrosis. These results highlight the importance of testing the activity of virulence determinants in the normal host background and in an infectious disease context and provide unequivocal evidence that it is the ability of alpha-toxin to form a pore that confers its toxicity in vivo.
Published ahead of print on 12 January 2009.
Present address: Monash Institute for Medical Research, Monash University, Clayton 3800, Australia.
Present address: Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»